67 results
Page 2 of 4
8-K
EX-10.1
l7zzngd1t71tu
14 Sep 22
Entry into a Material Definitive Agreement
5:11pm
8-K
EX-10.3
qbk1qrgrm0qmyv1uwp
14 Sep 22
Entry into a Material Definitive Agreement
5:11pm
8-K
tns1h5h4vi cf
21 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
EX-10.1
wg2sxhin4
4 Nov 21
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President
8:10am
8-K
EX-10.3
85t3j51ocbpdl8k8dk
4 Nov 21
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President
8:10am
8-K
EX-10.1
68iy0zgw
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
8-K
EX-99.1
mzd2kqqq5jxbmv2qmru
5 Mar 21
Company Presentation Confidential March 2021
8:41am
PRER14A
piun7hxzggde
2 Mar 21
Preliminary revised proxy
8:45am
PRE 14A
dn8674r1 k39gfa4bcc
2 Feb 21
Preliminary proxy
8:21am
8-K
EX-10.1
0jx96fh8cj9x6vvo
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.1
6oin12
8 Jan 21
Regulation FD Disclosure
4:05pm
8-K
EX-2.1
abrngk
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-10.1
w7e53
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm